Plasmalogen Precursor Supplements as a Potential Treatment for Traumatic Brain Injury

Date Published April 20, 2026

Northeast Neuroscience, Neurology and Cognitive Disorders

Investigating plasmalogen precursor supplements as a potential treatment for traumatic brain injury.

Plasmalogen Precursor Supplements as a Potential Treatment for Traumatic Brain Injury is a Rowan-led research project awarded support through the New Jersey Health Foundation's 2024 grant cycle. This project explores the potential of plasmalogen precursor supplements to serve as a therapeutic approach for individuals who have experienced traumatic brain injury (TBI).

Learn more

COM Affiliation

Rowan-Virtua School of Osteopathic Medicine

Funding Type

State Government Award

Update This Listing

Help us provide the most up-to-date information about this project.

Questions?

For questions about these research projects please email us.

This summary was generated by AACOM. The researchers and authors of this work were not involved in the curation of this summary.